marketing relationship

EISAI INDIA AND MYLAN ENTER INTO CO-EXCLUSIVE MARKETING AGREEMENTTO COMMERCILIZE TECERIS® THE SECOND ERIBULIN BRAND IN INDIA

TECERIS® aimed at expanding access to metastatic breast cancer patients in India Vishakhapatnam, September 29, 2019: Eisai Pharmaceuticals India Pvt.…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420